Loading...

Jaydutt V Vadgama

Title(s)Professor-in-Residence, Medicine
SchoolMedicine
Address760 Westwood Plaza 32-144
Los Angeles CA 90024
Phone(310) 563-4853
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Accelerating Excellence in Translational Science (AXIS)
    NIH/NIMHD U54MD007598Sep 28, 2009 - Jun 30, 2014
    Role: Principal Investigator
    Drew/UCLA Cancer Partnership Program
    NIH/NCI U56CA101599Aug 1, 2009 - Jul 31, 2010
    Role: Principal Investigator
    Charles R. Drew Student Scholar Program
    NIH/NIDDK R25DK067015Sep 30, 2003 - Jul 31, 2009
    Role: Principal Investigator
    REGULATION OF AMINO ACID TRANSPORT IN ERYTHROID CELLS
    NIH/NIDDK R29DK039147Aug 1, 1987 - Nov 30, 1992
    Role: Principal Investigator
    CDU-UCLA Cancer Center Partnership to Eliminate Cancer Health Disparities
    NIH/NCI U54CA143931
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Expression of MALAT1 Promotes Trastuzumab Resistance in HER2 Overexpressing Breast Cancers. Cancers (Basel). 2020 Jul 16; 12(7). Wu Y, Sarkissyan M, Ogah O, Kim J, Vadgama JV. PMID: 32708561.
      View in: PubMed   Mentions:
    2. EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells. Mol Cancer Ther. 2020 Aug; 19(8):1682-1695. Dillard C, Kiyohara M, Mah V, McDermott SP, Bazzoun D, Tsui J, Chan AM, Haddad G, Pellegrini M, Chang YL, Elshimali Y, Wu Y, Vadgama JV, Kim SR, Goodglick L, Law SM, Patel DD, Dhawan P, O'Brien NA, Gordon LK, Braun J, Lazar G, Wicha MS, Wadehra M. PMID: 32451329.
      View in: PubMed   Mentions:    Fields:    
    3. Transcriptional Regulation of CCL2 by PARP1 Is a Driver for Invasiveness in Breast Cancer. Cancers (Basel). 2020 May 21; 12(5). Dutta P, Paico K, Gomez G, Wu Y, Vadgama JV. PMID: 32455851.
      View in: PubMed   Mentions:
    4. Response of Breast Cancer Cells to PARP Inhibitors Is Independent of BRCA Status. J Clin Med. 2020 Mar 30; 9(4). Keung MY, Wu Y, Badar F, Vadgama JV. PMID: 32235451.
      View in: PubMed   Mentions:
    5. The role of PPM1D in cancer and advances in studies of its inhibitors. Biomed Pharmacother. 2020 May; 125:109956. Deng W, Li J, Dorrah K, Jimenez-Tapia D, Arriaga B, Hao Q, Cao W, Gao Z, Vadgama J, Wu Y. PMID: 32006900.
      View in: PubMed   Mentions: 1     Fields:    
    6. Bovine HDL and Dual Domain HDL-Mimetic Peptides Inhibit Tumor Development in Mice. J Cancer Res Ther Oncol. 2020; 8(1). Su F, Gm A, Palgunachari MN, White CR, Stessman H, Wu Y, Vadgama J, Pietras R, Nguyen D, Reddy ST, Farias-Eisner R. PMID: 32462055.
      View in: PubMed   Mentions:
    7. PP2Cd inhibits p300-mediated p53 acetylation via ATM/BRCA1 pathway to impede DNA damage response in breast cancer. Sci Adv. 2019 10; 5(10):eaaw8417. Li Q, Hao Q, Cao W, Li J, Wu K, Elshimali Y, Zhu D, Chen QH, Chen G, Pollack JR, Vadgama J, Wu Y. PMID: 31663018.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    8. A novel curcumin analog inhibits canonical and non-canonical functions of telomerase through STAT3 and NF-?B inactivation in colorectal cancer cells. Oncotarget. 2019 Jul 16; 10(44):4516-4531. Chung SS, Dutta P, Chard N, Wu Y, Chen QH, Chen G, Vadgama J. PMID: 31360301.
      View in: PubMed   Mentions: 2     Fields:    
    9. PARP Inhibitors as a Therapeutic Agent for Homologous Recombination Deficiency in Breast Cancers. J Clin Med. 2019 Mar 30; 8(4). Keung MYT, Wu Y, Vadgama JV. PMID: 30934991.
      View in: PubMed   Mentions:
    10. Utilization of NGS technologies to investigate transcriptomic and epigenomic mechanisms in trastuzumab resistance. Sci Rep. 2019 03 26; 9(1):5141. Nava M, Dutta P, Farias-Eisner R, Vadgama JV, Wu Y. PMID: 30914750.
      View in: PubMed   Mentions:    Fields:    
    11. A review of the effects of healthcare disparities on the experience and survival of ovarian cancer patients of different racial and ethnic backgrounds. J Cancer Metastasis Treat. 2019; 5. Kaufman M, Cruz A, Thompson J, Reddy S, Bansal N, Cohen JG, Wu Y, Vadgama J, Farias-Eisner R. PMID: 31236478.
      View in: PubMed   Mentions:
    12. AMP-activated protein kinase: a potential therapeutic target for triple-negative breast cancer. Breast Cancer Res. 2019 02 21; 21(1):29. Cao W, Li J, Hao Q, Vadgama JV, Wu Y. PMID: 30791936.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    13. Transcriptomic and ChIP-sequence interrogation of EGFR signaling in HER2+ breast cancer cells reveals a dynamic chromatin landscape and S100 genes as targets. BMC Med Genomics. 2019 02 08; 12(1):32. Nava M, Dutta P, Zemke NR, Farias-Eisner R, Vadgama JV, Wu Y. PMID: 30736768.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    14. Celecoxib in breast cancer prevention and therapy. Cancer Manag Res. 2018; 10:4653-4667. Li J, Hao Q, Cao W, Vadgama JV, Wu Y. PMID: 30464589.
      View in: PubMed   Mentions:
    15. Estrogen receptor-beta is a potential target for triple negative breast cancer treatment. Oncotarget. 2018 Sep 21; 9(74):33912-33930. Austin D, Hamilton N, Elshimali Y, Pietras R, Wu Y, Vadgama J. PMID: 30338035.
      View in: PubMed   Mentions: 5     Fields:    
    16. Combination of resveratrol and 5-flurouracil enhanced anti-telomerase activity and apoptosis by inhibiting STAT3 and Akt signaling pathways in human colorectal cancer cells. Oncotarget. 2018 Aug 31; 9(68):32943-32957. Chung SS, Dutta P, Austin D, Wang P, Awad A, Vadgama JV. PMID: 30250641.
      View in: PubMed   Mentions: 3     Fields:    
    17. Targeting of PP2Cd By a Small Molecule C23 Inhibits High Glucose-Induced Breast Cancer Progression In Vivo. Antioxid Redox Signal. 2019 06 10; 30(17):1983-1998. Wu K, Yu X, Huang Z, Zhu D, Yi X, Wu YL, Hao Q, Kemp KT, Elshimali Y, Iyer R, Nguyen KT, Zheng S, Chen G, Chen QH, Wang G, Vadgama JV, Wu Y. PMID: 29808718.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    18. MCP-1 is overexpressed in triple-negative breast cancers and drives cancer invasiveness and metastasis. Breast Cancer Res Treat. 2018 Aug; 170(3):477-486. Dutta P, Sarkissyan M, Paico K, Wu Y, Vadgama JV. PMID: 29594759.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    19. Optimization Of Cancer Treatment Through Overcoming Drug Resistance. J Cancer Res Oncobiol. 2018; 1(2). Elshimali YI, Wu Y, Khaddour H, Wu Y, Gradinaru D, Sukhija H, Chung SS, Vadgama JV. PMID: 29932172.
      View in: PubMed   Mentions:
    20. Time to Clinical Follow-up after Abnormal Mammogram among African American and Hispanic Women. J Health Care Poor Underserved. 2018; 29(1):448-462. Petersen SS, Sarkissyan M, Wu Y, Clayton S, Vadgama JV. PMID: 29503311.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Receptors for Insulin-Like Growth Factor-2 and Androgens as Therapeutic Targets in Triple-Negative Breast Cancer. Int J Mol Sci. 2017 Nov 02; 18(11). Hamilton N, Austin D, Márquez-Garbán D, Sanchez R, Chau B, Foos K, Wu Y, Vadgama J, Pietras R. PMID: 29099049.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    22. Association of Vitamin D3 Level with Breast Cancer Risk and Prognosis in African-American and Hispanic Women. Cancers (Basel). 2017 Oct 24; 9(10). Wu Y, Sarkissyan M, Clayton S, Chlebowski R, Vadgama JV. PMID: 29064397.
      View in: PubMed   Mentions:
    23. Proinflammatory Cytokines IL-6 and TNF-a Increased Telomerase Activity through NF-?B/STAT1/STAT3 Activation, and Withaferin A Inhibited the Signaling in Colorectal Cancer Cells. Mediators Inflamm. 2017; 2017:5958429. Chung SS, Wu Y, Okobi Q, Adekoya D, Atefi M, Clarke O, Dutta P, Vadgama JV. PMID: 28676732.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    24. GROa overexpression drives cell migration and invasion in triple negative breast cancer cells. Oncol Rep. 2017 Jul; 38(1):21-30. Bhat K, Sarkissyan M, Wu Y, Vadgama JV. PMID: 28560447.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    25. A83-01 inhibits TGF-ß-induced upregulation of Wnt3 and epithelial to mesenchymal transition in HER2-overexpressing breast cancer cells. Breast Cancer Res Treat. 2017 Jun; 163(3):449-460. Wu Y, Tran T, Dwabe S, Sarkissyan M, Kim J, Nava M, Clayton S, Pietras R, Farias-Eisner R, Vadgama JV. PMID: 28337662.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    26. Salinomycin Abolished STAT3 and STAT1 Interactions and Reduced Telomerase Activity in Colorectal Cancer Cells. Anticancer Res. 2017 02; 37(2):445-453. Chung SS, Adekoya D, Enenmoh I, Clarke O, Wang P, Sarkyssian M, Wu Y, Vadgama JV. PMID: 28179289.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    27. Aberrant Phosphorylation of SMAD4 Thr277-Mediated USP9x-SMAD4 Interaction by Free Fatty Acids Promotes Breast Cancer Metastasis. Cancer Res. 2017 03 15; 77(6):1383-1394. Wu Y, Yu X, Yi X, Wu K, Dwabe S, Atefi M, Elshimali Y, Kemp KT, Bhat K, Haro J, Sarkissyan M, Vadgama JV. PMID: 28115363.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    28. Lactate, a Neglected Factor for Diabetes and Cancer Interaction. Mediators Inflamm. 2016; 2016:6456018. Wu Y, Dong Y, Atefi M, Liu Y, Elshimali Y, Vadgama JV. PMID: 28077918.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    29. Long-term exposure of MCF-7 breast cancer cells to ethanol stimulates oncogenic features. Int J Oncol. 2017 Jan; 50(1):49-65. Gelfand R, Vernet D, Bruhn KW, Sarkissyan S, Heber D, Vadgama JV, Gonzalez-Cadavid NF. PMID: 27959387.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    30. Combination treatment with flavonoid morin and telomerase inhibitor MST-312 reduces cancer stem cell traits by targeting STAT3 and telomerase. Int J Oncol. 2016 Aug; 49(2):487-98. Chung SS, Oliva B, Dwabe S, Vadgama JV. PMID: 27279256.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    31. Long-term exposure of MCF-12A normal human breast epithelial cells to ethanol induces epithelial mesenchymal transition and oncogenic features. Int J Oncol. 2016 Jun; 48(6):2399-414. Gelfand R, Vernet D, Bruhn K, Vadgama J, Gonzalez-Cadavid NF. PMID: 27035792.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    32. Diabetes-associated dysregulated cytokines and cancer. Integr Cancer Sci Ther. 2016 Feb; 3(1):370-378. Wu Y, Liu Y, Dong Y, Vadgama J. PMID: 29930868.
      View in: PubMed   Mentions:
    33. Epithelial-Mesenchymal Transition and Breast Cancer. J Clin Med. 2016 Jan 26; 5(2). Wu Y, Sarkissyan M, Vadgama JV. PMID: 26821054.
      View in: PubMed   Mentions:
    34. Identification of Novel Biomarkers for Metastatic Colorectal Cancer Using Angiogenesis-Antibody Array and Intracellular Signaling Array. PLoS One. 2015; 10(8):e0134948. Chung S, Dwabe S, Elshimali Y, Sukhija H, Aroh C, Vadgama JV. PMID: 26258407.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    35. Understanding Perceived Benefit of Early Cancer Detection: Community-Partnered Research with African American Women in South Los Angeles. J Womens Health (Larchmt). 2015 Sep; 24(9):755-61. Bazargan M, Lucas-Wright A, Jones L, Vargas R, Vadgama JV, Evers-Manly S, Maxwell AE. PMID: 26131760.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    36. Combined inhibition of glycolysis and AMPK induces synergistic breast cancer cell killing. Breast Cancer Res Treat. 2015 Jun; 151(3):529-39. Wu Y, Sarkissyan M, Mcghee E, Lee S, Vadgama JV. PMID: 25975952.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    37. Biologic roles of estrogen receptor-ß and insulin-like growth factor-2 in triple-negative breast cancer. Biomed Res Int. 2015; 2015:925703. Hamilton N, Márquez-Garbán D, Mah V, Fernando G, Elshimali Y, Garbán H, Elashoff D, Vadgama J, Goodglick L, Pietras R. PMID: 25874233.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    38. Slug contributes to cancer progression by direct regulation of ERa signaling pathway. Int J Oncol. 2015 Apr; 46(4):1461-72. Li Y, Wu Y, Abbatiello TC, Wu WL, Kim JR, Sarkissyan M, Sarkissyan S, Chung SS, Elshimali Y, Vadgama JV. PMID: 25652255.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    39. Epigenetics in breast and prostate cancer. Methods Mol Biol. 2015; 1238:425-66. Wu Y, Sarkissyan M, Vadgama JV. PMID: 25421674.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimals
    40. Curcumin and epigallocatechin gallate inhibit the cancer stem cell phenotype via down-regulation of STAT3-NF?B signaling. Anticancer Res. 2015 Jan; 35(1):39-46. Chung SS, Vadgama JV. PMID: 25550533.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCells
    41. Estrogen Receptor-ß and the Insulin-Like Growth Factor Axis as Potential Therapeutic Targets for Triple-Negative Breast Cancer. Crit Rev Oncog. 2015; 20(5-6):373-90. Hamilton N, Marquez-Garban D, Mah VH, Elshimali Y, Elashoff D, Garon EB, Vadgama J, Pietras R. PMID: 27279236.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    42. Arctigenin in combination with quercetin synergistically enhances the antiproliferative effect in prostate cancer cells. Mol Nutr Food Res. 2015 Feb; 59(2):250-61. Wang P, Phan T, Gordon D, Chung S, Henning SM, Vadgama JV. PMID: 25380086.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    43. Increased chemopreventive effect by combining arctigenin, green tea polyphenol and curcumin in prostate and breast cancer cells. RSC Adv. 2014 Aug 05; 4(66):35242-35250. Wang P, Wang B, Chung S, Wu Y, Henning SM, Vadgama JV. PMID: 25243063.
      View in: PubMed   Mentions:
    44. IGF-1 regulates Cyr61 induced breast cancer cell proliferation and invasion. PLoS One. 2014; 9(7):e103534. Sarkissyan S, Sarkissyan M, Wu Y, Cardenas J, Koeffler HP, Vadgama JV. PMID: 25062088.
      View in: PubMed   Mentions: 16     Fields:    Translation:AnimalsCells
    45. Activation of Akt1 accelerates carcinogen-induced tumorigenesis in mammary gland of virgin and post-lactating transgenic mice. BMC Cancer. 2014 Apr 17; 14:266. Wu Y, Kim J, Elshimali Y, Sarkissyan M, Vadgama JV. PMID: 24742286.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    46. Vitamin D receptor FokI gene polymorphisms may be associated with colorectal cancer among African American and Hispanic participants. Cancer. 2014 May 01; 120(9):1387-93. Sarkissyan M, Wu Y, Chen Z, Mishra DK, Sarkissyan S, Giannikopoulos I, Vadgama JV. PMID: 24510435.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    47. Correlates of perceived risk of developing cancer among African-Americans in South Los Angeles. J Community Health. 2014 Feb; 39(1):173-80. Lucas-Wright A, Bazargan M, Jones L, Vadgama JV, Vargas R, Sarkissyan M, Smith J, Yazdanshenas H, Maxwell AE. PMID: 24026303.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    48. Constitutive activation of STAT3 signaling regulates hTERT and promotes stem cell-like traits in human breast cancer cells. PLoS One. 2013; 8(12):e83971. Chung SS, Aroh C, Vadgama JV. PMID: 24386318.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    49. STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits. Int J Oncol. 2014 Feb; 44(2):403-11. Chung SS, Giehl N, Wu Y, Vadgama JV. PMID: 24297508.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansAnimalsCells
    50. Triple negative breast tumors in African-American and Hispanic/Latina women are high in CD44+, low in CD24+, and have loss of PTEN. PLoS One. 2013; 8(10):e78259. Wu Y, Sarkissyan M, Elshimali Y, Vadgama JV. PMID: 24167614.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCTClinical Trials
    51. The clinical utilization of circulating cell free DNA (CCFDNA) in blood of cancer patients. Int J Mol Sci. 2013 Sep 13; 14(9):18925-58. Elshimali YI, Khaddour H, Sarkissyan M, Wu Y, Vadgama JV. PMID: 24065096.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansCells
    52. Genomic and functional characterizations of phosphodiesterase subtype 4D in human cancers. Proc Natl Acad Sci U S A. 2013 Apr 09; 110(15):6109-14. Lin DC, Xu L, Ding LW, Sharma A, Liu LZ, Yang H, Tan P, Vadgama J, Karlan BY, Lester J, Urban N, Schummer M, Doan N, Said JW, Sun H, Walsh M, Thomas CJ, Patel P, Yin D, Chan D, Koeffler HP. PMID: 23536305.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    53. Vitamin D receptor gene polymorphisms and prognosis of breast cancer among African-American and Hispanic women. PLoS One. 2013; 8(3):e57967. Mishra DK, Wu Y, Sarkissyan M, Sarkissyan S, Chen Z, Shang X, Ong M, Heber D, Koeffler HP, Vadgama JV. PMID: 23554871.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCTClinical Trials
    54. Comparing perceived and test-based knowledge of cancer risk and prevention among Hispanic and African Americans: an example of community participatory research. Ethn Dis. 2013; 23(2):210-6. Jones L, Bazargan M, Lucas-Wright A, Vadgama JV, Vargas R, Smith J, Otoukesh S, Maxwell AE. PMID: 23530303.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    55. Expression of Wnt3 activates Wnt/ß-catenin pathway and promotes EMT-like phenotype in trastuzumab-resistant HER2-overexpressing breast cancer cells. Mol Cancer Res. 2012 Dec; 10(12):1597-606. Wu Y, Ginther C, Kim J, Mosher N, Chung S, Slamon D, Vadgama JV. PMID: 23071104.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansCells
    56. Expression of FOXO1 is associated with GATA3 and Annexin-1 and predicts disease-free survival in breast cancer. Am J Cancer Res. 2012; 2(1):104-15. Wu Y, Elshimali Y, Sarkissyan M, Mohamed H, Clayton S, Vadgama JV. PMID: 22206049.
      View in: PubMed   Mentions:
    57. IGF gene polymorphisms and breast cancer in African-American and Hispanic women. Int J Oncol. 2011 Jun; 38(6):1663-73. Sarkissyan M, Mishra DK, Wu Y, Shang X, Sarkissyan S, Vadgama JV. PMID: 21455574.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    58. Expression of connective tissue growth factor (CTGF/CCN2) in breast cancer cells is associated with increased migration and angiogenesis. Int J Oncol. 2011 Jun; 38(6):1741-7. Chien W, O'Kelly J, Lu D, Leiter A, Sohn J, Yin D, Karlan B, Vadgama J, Lyons KM, Koeffler HP. PMID: 21455569.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    59. Obesity is associated with breast cancer in African-American women but not Hispanic women in South Los Angeles. Cancer. 2011 Aug 15; 117(16):3814-23. Sarkissyan M, Wu Y, Vadgama JV. PMID: 21305540.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    60. FOXO1A is a target for HER2-overexpressing breast tumors. Cancer Res. 2010 Jul 01; 70(13):5475-85. Wu Y, Shang X, Sarkissyan M, Slamon D, Vadgama JV. PMID: 20551062.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    61. Caspase 8 and maspin are downregulated in breast cancer cells due to CpG site promoter methylation. BMC Cancer. 2010 Feb 04; 10:32. Wu Y, Alvarez M, Slamon DJ, Koeffler P, Vadgama JV. PMID: 20132554.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    62. Global methylation pattern of genes in androgen-sensitive and androgen-independent prostate cancer cells. Mol Cancer Ther. 2010 Jan; 9(1):33-45. Mishra DK, Chen Z, Wu Y, Sarkissyan M, Koeffler HP, Vadgama JV. PMID: 20053773.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    63. Role of caspases in 5-FU and selenium-induced growth inhibition of colorectal cancer cells. Anticancer Res. 2008 Nov-Dec; 28(6A):3579-92. Thant AA, Wu Y, Lee J, Mishra DK, Garcia H, Koeffler HP, Vadgama JV. PMID: 19189638.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    64. Clinical significance of Akt and HER2/neu overexpression in African-American and Latina women with breast cancer. Breast Cancer Res. 2008; 10(1):R3. Wu Y, Mohamed H, Chillar R, Ali I, Clayton S, Slamon D, Vadgama JV. PMID: 18184439.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    65. Clinical significance of incidental colorectal wall thickening on computed tomography scan in African-American and Hispanic patients. Dig Dis Sci. 2007 Nov; 52(11):3159-64. Padda M, Vadgama J, Sandhu P, Dev A, Giannikopoulos I. PMID: 17404851.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    66. Taxol induced apoptosis regulates amino acid transport in breast cancer cells. Apoptosis. 2007 Mar; 12(3):593-612. Wu Y, Shen D, Chen Z, Clayton S, Vadgama JV. PMID: 17195090.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    67. Insulin-like growth factor I differentially regulates the expression of HIRF1/hCAF1 and BTG1 genes in human MCF-7 breast cancer cells. Int J Mol Med. 2006 Jul; 18(1):129-39. Vadgama JV, Scuric Z, Chakrabarti R, Marzo E, Shen D, Wu Y. PMID: 16786164.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    68. Novel Gemini-vitamin D3 analog inhibits tumor cell growth and modulates the Akt/mTOR signaling pathway. J Steroid Biochem Mol Biol. 2006 Aug; 100(4-5):107-16. O'Kelly J, Uskokovic M, Lemp N, Vadgama J, Koeffler HP. PMID: 16777406.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    69. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer. Clin Cancer Res. 2005 May 01; 11(9):3184-90. Gery S, Tanosaki S, Bose S, Bose N, Vadgama J, Koeffler HP. PMID: 15867211.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    70. Plasma vascular endothelial growth factor is useful in assessing progression of breast cancer post surgery and during adjuvant treatment. Int J Oncol. 2002 Mar; 20(3):509-16. Wu Y, Saldana L, Chillar R, Vadgama JV. PMID: 11836562.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    71. Role of estrogen receptor in the regulation of estrogen induced amino acid transport of System A in breast cancer and other receptor positive tumor cells. Int J Mol Med. 2002 Mar; 9(3):271-9. Bhat HK, Vadgama JV. PMID: 11836633.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    72. Effect of selenium in combination with Adriamycin or Taxol on several different cancer cells. Anticancer Res. 2000 May-Jun; 20(3A):1391-414. Vadgama JV, Wu Y, Shen D, Hsia S, Block J. PMID: 10928049.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    Jaydutt's Networks
    Concepts (346)
    Derived automatically from this person's publications.
    _
    Co-Authors (11)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _